Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data
about
Challenges of Using High-Dose Fractionation Radiotherapy in Combination TherapyIn silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroidsIcaritin synergistically enhances the radiosensitivity of 4T1 breast cancer cells.Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase IIDNA topoisomerase I drugs and radiotherapy for lung cancer.High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.Radiation oncology in vitro: trends to improve radiotherapy through molecular targets.Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr.Reirradiation with stereotactic body radiotherapy: analysis of human spinal cord tolerance using the generalized linear-quadratic model.Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors.Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.
P2860
Q26742107-F544C375-0C4F-45A6-A24D-FFC8CEC90822Q28535111-5638CCEC-2D1D-4C9D-9212-4BB94336CDCEQ34970960-89D220EB-4DB4-4E33-8F6F-94C4AF1DB372Q35997579-24D878E5-BA33-48A2-B825-652484335B79Q36186315-A2BE258B-EEE5-42D6-AE09-6F5DB62FFCC2Q37114850-2D633C40-9CCC-450D-B264-C99ECD1791BBQ37152509-32811BF4-A1D5-461A-BB4A-36582DCAB6D5Q38258770-70417B23-2322-493F-9CA8-CC8FDC178B4BQ38848051-8612856B-4720-47EB-92B7-483731DFE8BCQ39411133-99850942-9199-4762-8B5E-65381FACF47EQ41670896-9E5A8202-B602-41B3-ABD7-D212F5E867D6Q41888159-DCFE5437-B848-4A35-BBA5-0EF4011E37ADQ42659931-7C376ADB-2074-48FA-BC79-1CF0D77F59CD
P2860
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Can drugs enhance hypofraction ...... sitization using in vitro data
@ast
Can drugs enhance hypofraction ...... sitization using in vitro data
@en
Can drugs enhance hypofraction ...... sitization using in vitro data
@nl
type
label
Can drugs enhance hypofraction ...... sitization using in vitro data
@ast
Can drugs enhance hypofraction ...... sitization using in vitro data
@en
Can drugs enhance hypofraction ...... sitization using in vitro data
@nl
prefLabel
Can drugs enhance hypofraction ...... sitization using in vitro data
@ast
Can drugs enhance hypofraction ...... sitization using in vitro data
@en
Can drugs enhance hypofraction ...... sitization using in vitro data
@nl
P2860
P1476
Can drugs enhance hypofraction ...... sitization using in vitro data
@en
P2093
Nitin Ohri
Yaacov Richard Lawrence
P2860
P304
P356
10.1016/J.IJROBP.2011.06.1990
P407
P577
2012-01-19T00:00:00Z